Phantom for diffusion MRI imaging
A phantom calibration body ( 12 ) for calibrating diffusion MRI device ( 16 ) that mimics a material such as a mammalian tissue is disclosed. The phantom calibration body ( 12 ) includes a homogeneous aqueous solution ( 30 ) that contains a mixture of low molecular-weight and high molecular-weight polymers housed in a container ( 14 ) that is placed in the diffusion MRI device ( 16 ) for obtaining one or more diffusion MRI images of the phantom calibration body ( 12 ). A measure of diffusivity is calculated for each of the one or more diffusion MRI images in order to calibrate the diffusion MRI device. Methods of using the phantom calibration body ( 12 ) to calibrate diffusion MRI device ( 16 ) are also disclosed.
1. A system that performs diffusion magnetic resonance imaging (MRI), comprising: a phantom calibration body comprising:
a homogenous aqueous solution of polyvinyl pyrrolidone having a distribution of molecular weights with a mean of 5-1000 kilo Daltons (kDa);
the homogenous aqueous solution having a diffusivity that is essentially the same as a target mammalian tissue and a viscosity ranging from about 10 2 centistokes (cSt) to about 10 6 cSt; and,
a diffusion MRI device configured for scanning the phantom calibration body in order to generate diffusion imaging data of the phantom calibration body,
wherein the MRI device comprises one or more processors and
wherein the diffusion imaging data are provided and stored on at least one of the one or more processors.
2. The system of claim 1 , wherein the homogeneous aqueous solution comprises at least 0.1% (w/w) polyvinyl pyrrolidone.
3. The system of claim 1 , wherein the homogeneous aqueous solution comprises 1% to 80% (w/w) polyvinyl pyrrolidone.
4. The system of claim 1 , wherein the homogeneous aqueous solution comprises 5% to 20% (w/w) polyvinyl pyrrolidone.
5. The system of claim 1 , wherein the homogeneous aqueous solution comprises 20% to 80% (w/w) polyvinyl pyrrolidone.
6. The system of claim 1 , wherein the distribution of molecular weights has a mean of 5 to 40 kDa.
7. The system of claim 1 , wherein the distribution of molecular weights has a mean of 40-1000 kDa.
8. A method of diffusion MRI, comprising:
providing the system of claim 1 ;
placing the phantom calibration body of claim 1 into the diffusion MRI device of claim 1 ;
obtaining diffusion imaging data of the phantom calibration body by scanning the phantom calibration body with the diffusion MRI device; and
calculating a diffusivity measurement based on the diffusion imaging data that is indicative of water diffusivity of the homogeneous aqueous solution,
wherein the diffusivity measurement is calculated and provided back into the MRI device as a result by at least one of the one or more processors.
9. The method of claim 8 , wherein the diffusion MRI is performed in order to calibrate the diffusion MRI device.
10. The method of claim 9 , wherein the calibration is performed as part of an activity selected from the group consisting of:
a routine maintenance of the diffusion MRI device,
a troubleshooting and repair process on the diffusion MRI device,
a quality assurance/quality control process on the diffusion MRI device, and
a performance assessment of a prototype diffusion MRI device in a design process.
11. A method of diffusion magnetic resonance imaging (MRI), comprising:
providing a phantom calibration body comprising:
a homogenous aqueous solution of polyvinyl pyrrolidone having a distribution of molecular weights with a mean of 5-1000 kilo Daltons (kDa);
the homogenous aqueous solution having a diffusivity that is essentially the same as a target mammalian tissue and a viscosity ranging from about 10 2 centistokes (cSt) to about 10 6 cSt;
placing the phantom calibration body in a diffusion MRI device;
obtaining diffusion imaging data of the phantom calibration body by scanning the phantom calibration body with the diffusion MRI device,
wherein the MRI device comprises:
one or more processors and
wherein the diffusion imaging data are stored on at least one of the one or more processors; and
calculating a diffusivity measurement based on the diffusion imaging data that is indicative of water diffusivity of the homogeneous aqueous solution,
wherein the diffusivity measurement is calculated and provided back into the MRI device as a result by at least one of the one or more processors.
12. The method of claim 11 , wherein the diffusion MRI is performed in order to calibrate the diffusion MRI device.
13. The method of claim 12 , wherein the calibration is performed as part of an activity selected from the group consisting of:
a routine maintenance of the diffusion MRI device,
a troubleshooting and repair process on the diffusion MRI device,
a quality assurance/quality control process on the diffusion MRI device, and
a performance assessment of a prototype diffusion MRI device in a design process.
14. The method of claim 11 , wherein the homogeneous aqueous solution comprises at least 0.1% (w/w) polyvinyl pyrrolidone.
15. The method of claim 11 , wherein the homogeneous aqueous solution comprises 1% to 80% (w/w) polyvinyl pyrrolidone.
16. The method of claim 11 , wherein the homogeneous aqueous solution comprises 5% to 20% (w/w) polyvinyl pyrrolidone.
17. The method of claim 11 , wherein the homogeneous aqueous solution comprises 20% to 80% (w/w) polyvinyl pyrrolidone.
18. The method of claim 11 , wherein the distribution of molecular weights has a mean of 5 to 40 kDa.
19. The method of claim 11 , wherein the distribution of molecular weights has a mean of 40-1000 kDa.